D. E. Shaw & Co »

Apogee Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.9M 50k 58.74
2024-06-30 $2.0M 52k 39.35

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Netflix Put Option (NFLX)
Booking Holdings Call Option (BKNG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation (BAC)
Palantir Technologies Cl A (PLTR)
Citigroup Com New Put Option (C)

View all positions for D. E. Shaw & Co

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Rtw Investments
Driehaus Capital Management
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners

View all funds holding Apogee Therapeutics